Dennis C Sgroi

5PUBLICATIONS
30CO-AUTHORS
Predictive and prognostic markersBiomedical imagingCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 20, 2024
Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial.

Eleftherios P Mamounas, Hanna Bandos, Priya Rastogi

|Feb 11, 2022
Breast Cancer Index Is a Predictive Biomarker of Treatment Benefit and Outcome from Extended Tamoxifen Therapy: Final Analysis of the Trans-aTTom Study.

John M S Bartlett, Dennis C Sgroi, Kai Treuner

|Aug 11, 2021
Prognostic Utility of Breast Cancer Index to Stratify Distant Recurrence Risk in Invasive Lobular Carcinoma.

Raquel Nunes, Tal Sella, Kai Treuner

|Jun 19, 2021
CD8+ T cell immunity blocks the metastasis of carcinogen-exposed breast cancer.

Kaiwen Li, Tiancheng Li, Zhaoyi Feng

|Oct 24, 2018
Discrepancy in risk assessment of hormone receptor positive early-stage breast cancer patients using breast cancer index and recurrence score.

Piiha-Lotta Jerevall, Jane Brock, Juan Palazzo

Pageof 1